Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

HBB and thalassemia are reported together in 6 articles.

Gene

HBB

HGNC
HGNC:4827
38articles
38mentions
2variants with confirmed gene link
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
Phenotype

Thalassemia

HPO
HP:0001878
409articles
409mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

6 records shown · first 60
TypeEntitySource evidenceConfidenceExtractor
geneHBB“The first major group comprises cis-acting variants within globin gene clusters (HBG2 promoter XmnI polymorphism, HBB promoter mutations and α-globin enhancer variants), while the second major group comprises trans-acting quantitative trait loci (QTLs) (BCL11A and HBS1L-MYB loci).”0.98hgnc_dict_v1
phenotypethalassemia“Systematic Review of Non-Coding Genomic Variants in Globin and Non-Globin Clusters and Their Impact on Phenotypic Severity in Thalassemia and Sickle Cell Disease.”0.98phenotype_alias_lexicon_v2
geneHBG2“The first major group comprises cis-acting variants within globin gene clusters (HBG2 promoter XmnI polymorphism, HBB promoter mutations and α-globin enhancer variants), while the second major group comprises trans-acting quantitative trait loci (QTLs) (BCL11A and HBS1L-MYB loci).”0.98hgnc_dict_v1
geneBCL11A“The first major group comprises cis-acting variants within globin gene clusters (HBG2 promoter XmnI polymorphism, HBB promoter mutations and α-globin enhancer variants), while the second major group comprises trans-acting quantitative trait loci (QTLs) (BCL11A and HBS1L-MYB loci).”0.98hgnc_dict_v1

Identification of seven novel variants in the β-globin gene in transfusion-dependent and normal patients.

PMID 32190157 | PMCID PMC7069418 | DOI 10.5114/aoms.2019.84825 · Archives of medical science : AMS · 2020 · 12 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneHBB“INTRODUCTION: Abnormality in HBB results in an inherited recessive blood disorder, which can be caused by variants at the transcriptional or translational level affecting the stability and the production of the HBB chain.”0.98hgnc_dict_v1
phenotypethalassemia“The identified β-globin mutations will strengthen the genetic reference that could aid in characterizing mutations that are associated with phenotype of thalassemia in a specific region.”0.98phenotype_alias_lexicon_v2
geneHBA1“MATERIAL AND METHODS: Direct sequence of β-globin HBB gene, and alpha-globin HBA1 and HBA2 genes was performed on a total of 545 blood samples (transfusion-dependent: 215, 106 men and 109 women; normal healthy subjects: 330, 197 men and 133 women) collected from Saudi Arabian participants in the Eastern region.”0.98hgnc_dict_v1
geneHBA2“MATERIAL AND METHODS: Direct sequence of β-globin HBB gene, and alpha-globin HBA1 and HBA2 genes was performed on a total of 545 blood samples (transfusion-dependent: 215, 106 men and 109 women; normal healthy subjects: 330, 197 men and 133 women) collected from Saudi Arabian participants in the Eastern region.”0.98hgnc_dict_v1

CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.

PMID 32912325 | PMCID PMC7488347 | DOI 10.1186/s13287-020-01876-4 · Stem cell research & therapy · 2020 · 4 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneHBB“BACKGROUND: β-Thalassemias represent a group of genetic disorders caused by human hemoglobin beta (HBB) gene mutations.”0.98hgnc_dict_v1
phenotypethalassemia“CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.”0.93phenotype_alias_lexicon_v2
geneCD34“METHODS AND RESULTS: We successfully isolated CD34+ cells from peripheral blood of β-thalassemia patients with IVS-1-110 mutation.”0.98hgnc_dict_v1
variantIVS-1-110“CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.”0.82literature_variant_regex_v2
TypeEntitySource evidenceConfidenceExtractor
geneHBB“Most of the defects in hemoglobin arise directly from the mutations in the structural β-globin gene (HBB).”0.98hgnc_dict_v1
phenotypethalassemia“Beta-thalassemia is described as a group of hereditary blood disorders characterized by abnormalities in the synthesis of beta chains of hemoglobin.”0.93phenotype_alias_lexicon_v2
TypeEntitySource evidenceConfidenceExtractor
geneHBB“Beta-thalassemia is a genetic disorder that is caused by variations in the beta-hemoglobin (HBB) gene.”0.98hgnc_dict_v1
phenotypethalassemia“A comprehensive review of the prevalence of beta globin gene variations and the co-inheritance of related gene variants in Saudi Arabians with beta-thalassemia.”0.93phenotype_alias_lexicon_v2
geneATRX“The coinheritance of HBB gene variations with ATRX, HBA1, HBA2, HBA12, AHSP, and KLF1 gene variations were observed to be common in the Saudi population.”0.98hgnc_dict_v1
geneHBA1“The coinheritance of HBB gene variations with ATRX, HBA1, HBA2, HBA12, AHSP, and KLF1 gene variations were observed to be common in the Saudi population.”0.98hgnc_dict_v1

Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.

PMID 26076396 | DOI 10.3109/03630269.2015.1053489 · Hemoglobin · 2015 · 3 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneHBB“There were 41 patients, made up of 20 with β-thalassemia intermedia (β-TI), 18 with Hb H (β4) disease and three with Hb E (HBB: c.79G > A)-β-thalassemia (Hb E-β-thal); their ages ranged from 3 to 36 years (mean 12.5 ± 7.7).”0.98hgnc_dict_v1
phenotypethalassemia“Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.”0.98phenotype_alias_lexicon_v2
populationSaudi Arabia“There were 41 patients, made up of 20 with β-thalassemia intermedia (β-TI), 18 with Hb H (β4) disease and three with Hb E (HBB: c.79G > A)-β-thalassemia (Hb E-β-thal); their ages ranged from 3 to 36 years (mean 12.5 ± 7.7). The most common mutations among the β-TI patients were IVS-II-1 (G > A) and IVS-I-6 (T > C), while among the Hb H patients, the Saudi α2-globin gene polyadenylation (polyA) (AATAAA > AATAAG) mutation was responsible for all cases either as homozygotes (61.1%) or compound heterozygotes with the α-thal-2 (-α(3.7)) allele (33.3%).”0.95saudi_context_rules_v1